{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:31:09Z","timestamp":1781476269365,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jad.2025.119526","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:33:58Z","timestamp":1748414038000},"page":"119526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Investigating the efficacy of levetiracetam as an adjunct to olanzapine for acute manic episodes of bipolar disorder: A double-blind placebo-controlled randomized clinical trial"],"prefix":"10.1016","volume":"387","author":[{"given":"Hasan","family":"Mirzazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nourollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Assadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Bordbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Razeghian","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Moshfeghinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119526_bb0005","series-title":"Diagnostic and statistical manual of mental disorders. Text revision","author":"Association AP","year":"2000"},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis","volume":"19","author":"Barton","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"issue":"8","key":"10.1016\/j.jad.2025.119526_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hup.1249","article-title":"Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study","volume":"26","author":"Chen","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"9799","key":"10.1016\/j.jad.2025.119526_bb0025","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119526_bb0035","first-page":"268","article-title":"Psychometric assessment of beck scale for suicidal ideation (BSSI) in general population in Tehran","volume":"29","author":"Esfahani","year":"2015","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"10027","key":"10.1016\/j.jad.2025.119526_bb0040","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jad.2025.119526_bb0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4088\/JCP.v64n0707","article-title":"Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design","volume":"64","author":"Grunze","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"20","key":"10.1016\/j.jad.2025.119526_bb0050","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jad.2025.119526_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1017\/S1092852916000079","article-title":"Bipolar and related disorders in DSM-5 and ICD-10","volume":"21","author":"Kaltenboeck","year":"2016","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000520457","article-title":"Levetiracetam as an adjunctive treatment for mania: a double-blind, randomized, placebo-controlled trial","volume":"81","author":"Keshavarzi","year":"2022","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"27","author":"Kishi","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00213-008-1109-8","article-title":"Levetiracetam as monotherapy or add-on to valproate in the treatment of acute mania-a randomized open-label study","volume":"198","author":"Kr\u00fcger","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.jad.2025.119526_bb0075","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.25","article-title":"Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis","volume":"67","author":"Li","year":"2024","journal-title":"Eur. Psychiatry"},{"issue":"10265","key":"10.1016\/j.jad.2025.119526_bb0080","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0085","first-page":"175","article-title":"Psychometric properties of the Young mania rating scale as a mania severity measure in patients with bipolar I disorder","volume":"6","author":"Mohammadi","year":"2018","journal-title":"Practice in Clinical Psychology"},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.v66n0314","article-title":"Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder","volume":"66","author":"Post","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","article-title":"Diverse mechanisms of antiepileptic drugs in the development pipeline","volume":"69","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jad.2025.119526_bb0100","series-title":"StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024","author":"Thomas","year":"2024"},{"issue":"3","key":"10.1016\/j.jad.2025.119526_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1570159X14666160606210811","article-title":"Depression and mania in bipolar disorder","volume":"15","author":"Tondo","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2025.119526_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2015.07.004","article-title":"The adverse event profile of levetiracetam: a meta-analysis on children and adults","volume":"31","author":"Verrotti","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jad.2025.119526_bb0115","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.jad.2025.119526_bb0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12264-023-01138-2","article-title":"Development of SV2A ligands for epilepsy treatment: a review of levetiracetam, brivaracetam, and padsevonil","volume":"40","author":"Wu","year":"2024","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jad.2025.119526_bb0125","first-page":"1265","article-title":"Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group","volume":"11","author":"Xu","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.119526_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119526_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YIC.0000000000000383","article-title":"Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability","volume":"37","author":"Zarezadeh","year":"2022","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:59:38Z","timestamp":1749887978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725009681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0165032725009681"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119526","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the efficacy of levetiracetam as an adjunct to olanzapine for acute manic episodes of bipolar disorder: A double-blind placebo-controlled randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119526"}}